We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+12.21%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$53.1B
AUM Growth
+$4.7B
(+9.7%)
Cap. Flow
-$415M
Cap. Flow
% of AUM
-0.78%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
2,495
New
186
Increased
937
Reduced
1,188
Closed
172
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$144M |
| 2 |
NVIDIA
NVDA
|
+$137M |
| 3 |
GE Aerospace
GE
|
+$129M |
| 4 |
Dell
DELL
|
+$91.3M |
| 5 |
Comcast
CMCSA
|
+$88.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$103M |
| 2 |
Microchip Technology
MCHP
|
+$98.3M |
| 3 |
Steel Dynamics
STLD
|
+$87M |
| 4 |
UnitedHealth
UNH
|
+$79.5M |
| 5 |
Walmart Inc
WMT
|
+$79.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.58% |
| 2 | Consumer Discretionary | 13.58% |
| 3 | Healthcare | 12.97% |
| 4 | Financials | 12.15% |
| 5 | Industrials | 12.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
ChargePoint
CHPT
$158M
| $109K | ﹤0.01% |
+2,334
| New | +$131K |
|
2277
Innodata
INOD
$2.03B
| $108K | ﹤0.01% |
13,268
+227
| +2% | +$1.8K |
|
|
HBI
2278
DELISTED
Hanesbrands
HBI
| $105K | ﹤0.01% |
+23,607
| New | +$96.1K |
|
2279
Sana Biotechnology
SANA
$1B
| $99.2K | ﹤0.01% |
+24,317
| New | +$89.6K |
|
2280
SmartRent
SMRT
$261M
| $98.7K | ﹤0.01% |
+30,943
| New | +$90.3K |
|
2281
Banco Bilbao Vizcaya Argentaria
BBVA
$156B
| $94.1K | ﹤0.01% |
+10,324
| New | +$88.8K |
|
2282
Algonquin Power & Utilities
AQN
$4.36B
| $91.7K | ﹤0.01% |
14,514
+76
| +0.5% | +$444 |
|
|
KLRS
2283
Kalaris Therapeutics
KLRS
$93.7M
| $84.6K | ﹤0.01% |
+5,409
| New | +$213K |
|
|
PGRE
2284
DELISTED
Paramount Group
PGRE
| $80.5K | ﹤0.01% |
15,576
-2,057
| -12% | -$9.76K |
|
2285
Torrid Holdings
CURV
$249M
| $79.8K | ﹤0.01% |
+13,833
| New | +$47.3K |
|
|
PSTX
2286
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $79.4K | ﹤0.01% |
23,640
-63,343
| -73% | -$163K |
|
|
ORGN
2287
DELISTED
Origin Materials
ORGN
| $77.2K | ﹤0.01% |
3,077
+1,823
| +145% | +$52.3K |
|
2288
Quad
QUAD
$507M
| $76.4K | ﹤0.01% |
14,088
+1,389
| +11% | +$6.78K |
|
2289
Tenaya Therapeutics
TNYA
$165M
| $75.8K | ﹤0.01% |
23,394
+8,649
| +59% | +$18.7K |
|
2290
Savara
SVRA
$1.17B
| $73.8K | ﹤0.01% |
+15,701
| New | +$60.2K |
|
|
MRSN
2291
DELISTED
Mersana Therapeutics
MRSN
| $73.2K | ﹤0.01% |
1,262
-4,465
| -78% | -$180K |
|
|
CUTR
2292
DELISTED
Cutera, Inc.
CUTR
| $70.9K | ﹤0.01% |
+20,116
| New | +$61.3K |
|
2293
ThredUp
TDUP
$424M
| $70.1K | ﹤0.01% |
+31,174
| New | +$81K |
|
|
CBD
2294
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $69.7K | ﹤0.01% |
87,121
-263,312
| -75% | -$186K |
|
2295
Vanda Pharmaceuticals
VNDA
$304M
| $68.6K | ﹤0.01% |
+16,245
| New | +$65.5K |
|
2296
Ginkgo Bioworks
DNA
$500M
| $66.3K | ﹤0.01% |
980
+393
| +67% | +$24.1K |
|
|
SCPH
2297
DELISTED
scPharmaceuticals
SCPH
| $64.2K | ﹤0.01% |
10,244
-600
| -6% | -$3.44K |
|
2298
Geron
GERN
$949M
| $63.3K | ﹤0.01% |
29,992
-47,243
| -61% | -$91.9K |
|
|
CANO
2299
DELISTED
Cano Health, Inc.
CANO
| $63.3K | ﹤0.01% |
10,779
+9,120
| +550% | +$108K |
|
2300
FuelCell Energy
FCEL
$1.59B
| $63K | ﹤0.01% |
1,313
-185
| -12% | -$7.08K |
|
Similar funds
VGA
AQR Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, AQR Capital Management held 2,495 positions worth $53.1B, up 9.7% from $48.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
AQR Capital Management's Q4 2023 filing shows 186 new, 937 increased, 1,188 reduced and 172 closed positions. Its largest new stake was NCR Atleos: 518,383 shares worth $12.5M. The largest sale was Pfizer, an estimated $103M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- AQR Capital Management's largest Q4 2023 buy was NCR Atleos: 518,383 shares worth $12.5M.
- AQR Capital Management added most to Amazon in Q4 2023, an estimated $144M increase.
- AQR Capital Management's biggest Q4 2023 reduction was Pfizer, cutting an estimated $103M.
- AQR Capital Management fully exited Activision Blizzard in Q4 2023, selling an estimated $38.5M.
- AQR Capital Management's ten largest holdings make up 15% of its $53.1B portfolio in Q4 2023.
- AQR Capital Management opened 186 new positions and closed 172 in Q4 2023.
- AQR Capital Management's portfolio value rose 9.7% quarter-over-quarter to $53.1B.
Based on AQR Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.